Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Am J Transplant. 2013 Feb 7;13(4):1012–1018. doi: 10.1111/ajt.12143

Table 1.

Candidate characteristics by initial waitlist status and subsequent activity, 2000–2011*

Always Inactive Started Inactive, But Active At Least Once Started Active, But Inactive At Least Once Always Active
N (%) 18,385 (7.0%) 31,431 (12.0%) 76,031 (28.9%) 136,977 (52.1%)
Age (mean, years) 53.4 51.7 52.0 51.0
Sex (%):
Male 6.9 12.0 28.7 52.5
Female 7.2 11.9 29.3 51.6
Race (%):
Caucasian 6.5 12.2 27.8 53.5
African-American 7.7 12.0 31.6 48.7
Other 7.2 11.4 28.0 53.4
Cause of Kidney Disease (%):
Glomerulonephritis 5.1 12.0 26.9 56.0
Diabetes 8.9 12.0 31.1 48.1
Congenital 5.0 13.2 25.5 56.4
Hypertension 7.1 11.8 29.6 51.5
Other 6.4 11.5 27.5 54.7
Dialysis Status at Listing (%):
Preemptive 7.5 13.5 24.4 54.7
Hemodialysis 6.4 10.9 31.0 51.7
Peritoneal Dialysis 4.7 11.4 30.9 53.0
BMI (mean, kg/m2) 29.7 28.6 28.4 27.7
Previous (non-kidney) transplant (%) 6.5 10.2 28.9 54.4
Diabetes (%) 8.8 12.0 30.9 48.3
Peripheral vascular disease (%) 9.9 12.5 33.6 44.0
Hepatitis C (%)** 4.2 7.6 21.8 66.3
Poor functional status (%) 8.2 9.2 29.3 53.3
Multi-listed (%) 1.2 15.3 39.7 43.9
Time spent active (mean, percentage) 0.0 59.5 65.3 100.0
Region (%):
1 (CT, ME, MA, NH, RI, East VT) 4.3 7.5 39.5 48.8
2 (DE, DC, MD, NJ, PA, WV, North VA) 7.3 11.6 24.6 56.5
3 (AL, AR, FL, GA, LA, MS, PR) 5.0 9.3 33.3 52.3
4 (OK, TX) 7.6 10.9 26.4 55.1
5 (AZ, CA, NV, NM, UT) 7.0 9.4 28.5 55.2
6 (AL, HI, ID, MT, OR, WA) 9.0 22.3 36.4 32.3
7 (IL, MN, ND, SD, WI) 7.4 14.1 23.2 55.4
8 (CO, IO, KS, MO, NE, WY) 4.2 19.9 27.7 48.2
9 (NY, West VT) 14.2 17.8 19.9 48.0
10 (IN, MI, OH) 2.3 8.2 40.0 49.6
11 (KY, NC, SC, TN, Southern VA) 8.7 13.3 29.8 48.2
*

For continuous variables, mean values reflect the cell-wise mean. For categorical variables, % reflects the row-wise percentage.

**

Candidate indicated a willingness to accept an HCV positive organ – used as a proxy for the candidate’s HCV status.